NeuroBo Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $15,886,000.
Profit Margin
| 2014 | 0 | -320K | |
|---|---|---|---|
| 2015 | 0 | -9.02M | |
| 2016 | 0 | -14.58M | |
| 2017 | 0 | -33.41M | |
| 2018 | 0 | -23.63M | |
| 2019 | 0 | -22.43M | |
| 2020 | 0 | -29.59M | |
| 2021 | 0 | -15.22M | |
| 2022 | 0 | -6.11M | |
| 2023 | 0 | -12.47M |
NRBO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 28K | 72K | 67K | 17K | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | -28K | -72K | -67K | -17K | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 9.15M | 2.77M | 6.54M | 21.87M | 17.47M | 14.31M | 22.68M | 8.74M | 3.99M | 52K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 10.37M | 0 | 0 | 0 |
Total operating expenses | 15.88M | 11.41M | 15.29M | 29.71M | 20.17M | 22.80M | 33.12M | 14.69M | 7.16M | 266K |
Operating income | -15.88M | -19.62M | -15.29M | -29.71M | -20.17M | -22.80M | -33.12M | -14.69M | -8.07M | -266K |
Other income (expenses), net | 3.41M | 5.66M | 14K | 38K | -1.13M | -178K | -291K | -4K | -953K | -54K |
Income before tax | -12.47M | -13.96M | -15.28M | -29.67M | -21.31M | -23.63M | -33.41M | -14.58M | -9.02M | -320K |
Income tax expense | 0 | -7.85M | -62K | -85K | 1.11M | 654K | 286K | 0 | -146K | 55K |
Net income | -12.47M | -6.11M | -15.22M | -29.59M | -22.43M | -23.63M | -33.41M | -14.58M | -9.02M | -320K |
Earnings per share | ||||||||||
Basic EPS | -2.46 | -19.01 | -157.85 | -437.95 | -1.03K | -166.8 | -2.42K | -1.88K | -1.27K | -45.27 |
Diluted EPS | -2.46 | -19.01 | -157.85 | -437.95 | -1.03K | -166.8 | -2.42K | -1.88K | -1.27K | -45.27 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |